We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Harvard University’s teaching hospital will adopt Echo IQ’s AI-based aortic stenosis detection tool...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleThe S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones I...
Read ArticleASX ends very modestly lower after a mixed session Newmont and Fortescue shares drop on disappoint...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleHealth Check is renowned biotech journo Tim Boreham’s daily wrap covering morning movers and shakers...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read Article‘Wheezo’ maker Respiri says a new US deal will help to propel the company to cash-flow break even b...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleASX up as earnings season rolls on; Origin down 10pc, Telstra up 3pc Australia’s unemployment rate...
Read ArticleOncoSil Medical (ASX: OSL) has announced a 78% increase in the number of doses of its OncoSil single...
Read ArticleOncosil Medical Ltd (ASX:OSL) has announced that a patient with pancreatic cancer was able to reduce...
Read ArticlePYC starts human trials for PYC-001 to treat rare eye disease OncoSil device successfully treats fi...
Read ArticleThe ASX dropped, dragged down by Real Estate and Mining stocks Qantas cuts former CEO’s compensatio...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleS&P/ASX 200 had its best month of the year in July finishing up 4% to record high S&P Dow J...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX rises on Monday after Wall Street banked a belter on Friday All 11 local sectors higher, InfoT...
Read ArticleGood morning (just), and welcome to Stockhead’s Top 10 at shortly-after-11-ish, which is meant to hi...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticlePancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has updated investors o...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThe ASX200 is down 1.1 per cent – on par with futures’ predictions – with every sector flashing red...
Read ArticleOncoSil Medical (ASX:OSL) released groundbreaking findings from a study which showed that the additi...
Read ArticleASX to open sharply lower as Wall Street spooked by strong US jobs data Cannabis stocks jumped a...
Read ArticleThe ASX belts one out on Monday, up 0.8pc All 11 sectors are better for it Canterbury Resources gro...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleThe ASX pared gains after the CPI came in stronger than expected Fortescue led the Mining sector af...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleThe ASX extends its gains on Tuesday Tech stocks rallied ahead of US megacap earnings, while goldie...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticlePancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has announced the first...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleOncoSil Medical (ASX:OSL), in its ongoing mission to develop treatments for pancreatic cancer, says...
Read ArticleThe ASX200 closed up slightly by +0.1% on Monday as gains in tech and gold stocks were offset by los...
Read ArticleThe ASX200 has closed down .56 of a per cent with IT down 1.4 per cent and in the red for a second s...
Read ArticleThe ASX200 is down nearly .7 of a per cent – almost on par with futures’ predictions – with most sec...
Read ArticleOncoSil Medical (ASX:OSL) – on its mission to combat pancreatic cancer – has now dosed the first two...
Read ArticleThe ASX200 ends Tuesday slightly lower Resources stocks hold the fort, everyone else AWOL Small Ca...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleThe ASX200 has ended Friday down 0.15pc, but ends week higher Property and Healthcare gains offset...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleLocal markets end hopelessly, slightly lower IT sector surges 2.9% Small Caps led by incredible...
Read ArticleLocal markets are lucky to close a smidgen higher IT and Healthcare sectors offset a 2pc loss for...
Read ArticleLocal markets end slightly lower Telco Sector jumps 1.5pc Small Caps led by Way2Vat The ASX200...
Read ArticleASX adds 0.7pc to close out the week in a positive frame of mind IT and materials rise, thanks to...
Read ArticleASX rises 0.77pc, hefted heavenward with the help of a huge tech buy InfoTech was the best of the...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX to gain on Wednesday after dovish comments from US Fed Gold price continues to climb, nears all...
Read ArticleASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleThe ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Smal...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleASX 200 benchmark rises almost 0.6% Tech Sector recovers Wednesday’s losses, after Nasdaq positivit...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleOncoSil Medical (OSL) gains ethics committee approval for its PANCOSIL trial, focused on treating pa...
Read ArticleOncoSil gets Ethics committee approval Starpharma’s nasal spray VIRALEZE granted approval in Malay...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleThe ASX fell this morning and – sadly – just never recovered. It’s down 0.64%. Aside from Happy Tim...
Read ArticleOncoSil Medical (ASX:OSL) has announced the first patient treatment in Italy with its OncoSi...
Read ArticleOncoSil Medical (OSL) treats its first patient in Italy with the Oncosil device, its flagship produc...
Read ArticleThe ASX opened lower this morning, while majority of the sectors dragged. Finance and communicati...
Read ArticleS&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining reg...
Read ArticleOncoSil Medical (OSL) enrols the first patient into its randomised clinical study of its namesake On...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleMedical device company OncoSil (ASX:OSL) has announced the findings of an oral presentation...
Read ArticleASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners ag...
Read ArticleASX 200 benchmark closes 0.11% lower after a fickle day on the bourse Iron ore price drops to five...
Read ArticleOncoSil Medical (OSL) makes further commercial progress in Spain with its namesake OncoSil brachythe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX down, then up, then down even further to -1.4% as bank crisis looms large. XEC Emerging Compani...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleOncoSil (OSL) treats its first commercial patients with its namesake device at two key treatment cen...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleOncoSil (OSL) treats its first ten patients with the OncoSil device in SpainSince treating the first...
Read ArticleOncoSil (OSL) signs a distribution agreement for the sale of its OncoSil device in selected Chinese...
Read ArticleClarity Pharma announced positive results from Phase 1 trial Starpharma brings VIRALEZE to Indonesi...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleShareCafeThe Week that Was: November 14-18, 2022 We at ShareCafe understand you are busy and may not...
Read ArticleShareCafeOncoSil Medical (ASX: OSL) – Targeted therapy for pancreatic cancer OncoSil Medical Limite...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleOncoSil Medical (OSL) treats its second patient in a locally advanced pancreatic cancer clinical tr...
Read ArticleHeraMED’s device is effective for telemedicine in monitoring pregnant women Mesoblast issues strong...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsi...
Read ArticleBupa UK Insurance becomes the first health insurance company to provide reimbursement for OncoSil M...
Read ArticleHitIQ and Volpara sign major deals in the US ECS Botanics makes first cannabis flower shipment to N...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleBenchmark lifts on uranium, energy gains Small caps on energy and materials Newcomer Southern Palla...
Read ArticleHighlights The benchmark ASX 200 was trading 0.59% up at 7,400.6 in the first 10 minutes of trad...
Read ArticleOncoSil Medical (OSL) signs its first commercial agreement in Spain for the OncoSil device with The...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleOncoSil Medical (OSL) places its shares in a trading halt pending the release of a capital raising...
Read ArticleHalo Technologies (HAL) shares have plunged 27.5 per cent since its ASX debut yesterday. The list...
Read ArticleLocal stocks hit cruise control heading into the Easter break, with steady gains across the ASX in a...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleOkay, who poked the S&P/ASX Emerging Companies index (XEC) this morning? Someone woke the sleepi...
Read ArticleToday is a good day for the OncoSil Medical Ltd (ASX: OSL) share price after the company released n...
Read ArticleOncoSil Medical (OSL) reports the company’s first commercial treatment of pancreatic cancer with th...
Read ArticleOncosil’s medical device is being used commercially for the first time in Europe NeuroScientific Bi...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleOncoSil Medical (OSL) receives approval to undertake a fully funded clinical trial of its OncoSil d...
Read ArticleHighlights OncoSil Medical has secured G-BA approval for a fully funded trial to evaluate its O...
Read ArticleOncosil’s medical device will be used in a German government funded clinical trial PainChek to expa...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleThe S&P/ASX200 pared earlier losses to finish ~0.2% lower. Wall Street lifted, but my word — th...
Read ArticleOncoSil Medical’s (OSL) device is approved for innovation funding for hospitals in Germany The Germ...
Read ArticleThe ASX 200 Health Index (XHJ) has fallen by 1.26% at the time of writing, compared to the broader i...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleThe OncoSil Medical Ltd (ASX: OSL) share price is soaring higher on Friday after the company announ...
Read ArticleOncoSil Medical (OSL) publishes the final results of the PanCO clinical study for its OncoSil devic...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.70% at the time of writing, compared to the br...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleAs the world emerges from the pandemic, markets are now contending with an energy crisis, a global s...
Read ArticleOncoSil Medical (ASX:OSL) has announced the appointment of Professor Ricky Sharma to its boa...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleSummary The S&P/ASX200 ended lower by just 10 basis points at 7,394.30, shedding early gains...
Read ArticleThe ASX clawed back initial gains to start the week, closing virtually flat today. The ASX 200 close...
Read ArticleSummary The ASX 200 has continued its momentum in the opening session, making a record high. Al...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleThe Oncosil Medical Ltd (ASX: OSL) share price finished in positive territory during late-afternoon...
Read ArticleOn a day the ASX finished nearly 0.5 per cent up, tech stood alone in the red losing more than 2 per...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read Article22 Jan 2021 - Medical device company, OncoSil Medical (ASX:OSL) has appointed Nigel Lange as Chief E...
Read ArticleThe Oncosil Medical Ltd (ASX: OSL) share price jumped 10% on Thursday after the company received re...
Read ArticleThe coronavirus pandemic has rocked almost every economy around the world, and Australia's is no exc...
Read ArticleShareCafeOncosil Medical – ShareCafe Hidden Gems Webinar Presentation Presenter – Daniel Kenny –...
Read ArticleShareCafeHidden Gems Webinar Recap – OSL, MDC, CYP, GSS We continue to unearth small-cap companie...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up th...
Read ArticleIn the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap di...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleOncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implanta...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleMedical device company OncoSil Medical (ASX: OSL) has announced that it has finally received the CE...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOncoSil Medical Ltd (ASX:OSL) has received CE Marking approval from the British Standards Institute...
Read ArticleOncoSil Medical Ltd (ASX:OSL) has received CE Marking approval from the British Standards Institute...
Read ArticleMedical device company OncoSil Medical (ASX: OSL) has been granted what’s known as breakthrough devi...
Read ArticleMedical device company OncoSil Medical (ASX: OSL) has been granted what’s known as breakthrough devi...
Read ArticleOncoSil Medical Ltd (ASX:OSL) today announced that the OncoSilTM device has reached a significant mi...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOncoSil Medical (ASX: OSL) has developed a first-in-class, truly innovative device that treats unres...
Read ArticleThe health sector was the most successful sector on the ASX in 2019. Various small caps made several...
Read ArticleThe coming 12 months is shaping up as a watershed stage in the history of Oncosil Medical Ltd (ASX:O...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleMedical devices are considered as an essential part of the health care industry and range from a ban...
Read ArticleMedical device company, OncoSil Medical Ltd (ASX: OSL) has provided updated on its CE Marking review...
Read ArticleIn this article we are discussing five ASX-listed health care stocks, Althea Group Holdings Limited...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealth care sector is one of the popular sectors among investors, as it is one of the high yielding...
Read ArticleThe notion of ‘everything old is new again’ applies not just to fickle fashion trends, but to drug d...
Read ArticleThe science of Regenerative Medicine is a rapidly emerging field linking the medical technology, bio...
Read ArticleZelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results f...
Read ArticleSince the ASX is flooded with quarterlies, we’ve summarised a list of the five health companies that...
Read ArticleIn this week’s recap of substantial holder movements four substantial holders bought shares in Zenit...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
